Medical visa to India for patients from Angola

Check details about a medical visa to India from Angola.

• CancerFax helps in getting a medical visa for medical treatment. A visa is granted for up to one year with triple entries, provided that registration is required after the patient reaches the country.
• If one seeks medical treatment in top specialized/recognized  hospitals in India.
• Up to  two attendants can accompany the patient who are closely related with him/her under separate attendant visas whose visa validity will be the same as the medical visa

Serious ailments like neurosurgery; ophthalmic disorders; heart-related problems; renal disorders; organ transplantation; congenital disorders; gene therapy; radio therapy; plastic surgery; joint replacement, etc. will be of primary consideration.

Medical visa to India for Angolans

For Medical Visa, a signed letter in original from the local hospital/doctor and copies of treatment record should be submitted along with letter from the Indian hospital/doctor in original indicating details of the proposed treatment.  For persons accompanying the applicant proof of relationship with the patient and a letter from the applicant is required.

Details of e-Visa:
e-Visa is a 60-day non-extendable, non-convertible, double entry Indian visa.
The entire process of e-Visa (application, payment and receiving the visa) is online.

Embassy of India in Luanda does not play any role in e-Visa process.
 Document required for medical e-visa

1. Scanned Bio Page of the passport showing the Photograph and Details
2. Copy of Letter from the Hospital concerned in India on its letterhead

The digital photograph to be uploaded along with the Visa application should meet the following requirements:

1. Format – JPEG
2. Size
   1. Minimum 10 KB
   2. Maximum 1 MB
3. The height and width of the Photo must be equal.
4. Photo should present full face, front view, eyes open and without spectacles.
5. Center head within frame and present full head from top of hair to bottom of chin
6. Background should be plain light colored or white background.
7. No shadows on the face or on the background.
8. Without borders.
9. Scanned Bio Page of the passport showing the Photograph and Details.
   1. Format -PDF
   2. Size : Minimum 10 KB ,Maximum 300 KB
10. Other document for Business/Medical Purpose
    1. Format -PDF
    2. Size : Minimum 10 KB ,Maximum 300 KB

The link for e- visa application is given below
https://indianvisaonline.gov.in/evisa
Do not rely on any other website

Indian Medical Visa Processing Fee

Medical visa is granted for 6 months with triple entries from Angola to India. It approximately costs 14760 Angolan Kwanza (89 USD).

Indian Medical Visa Processing Time

Indian medical visa from Angola will be issued on the same day of the submission of the application.
Contact Details and Working Hours of Indian High Commission in Angola

• Ambassador: Sushil Kumar Singhal
  • Email ID: amb.luanda@mea.gov.in
• First Secretary (Consular): consular.luanda@mea.gov.in
• General Enquiries: 222 038019, 931 521 458
• Consular Services: hoc.luanda@mea.gov.in
• Embassy Working Hours: 0830 hours – 1700 hours (Monday to Friday)
• Consular Working Hours: 0900 hours – 1200 hours (Monday to Friday)

Susan Hau

Website |  + postsBio ⮌

Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.

Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.

Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.

Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.

These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.

Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.

• Susan Hau

  https://cancerfax.com/author/susan/

  Datopotamab deruxtecan-dlnk is approved by the USFDA for EGFR-mutated non-small cell lung cancer
• Susan Hau

  https://cancerfax.com/author/susan/

  PiggyBac Transposon System: A Revolutionary Tool in Cancer Gene Therapy
• Susan Hau

  https://cancerfax.com/author/susan/

  Neoadjuvant and adjuvant pembrolizumab is approved by the USFDA for resectable locally advanced head and neck squamous cell carcinoma
• Susan Hau

  https://cancerfax.com/author/susan/

  Taletrectinib is approved by the USFDA for ROS1-positive non-small cell lung cancer

• Comments Closed
• June 23rd, 2018